BRAINTREE, Mass. (AP) — Haemonetics Corp. (HAE) on Tuesday reported fiscal second-quarter profit of $18.7 million.

On a per-share basis, the Braintree, Massachusetts-based company said it had profit of 35 cents. Earnings, adjusted for one-time gains and costs, came to 56 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 54 cents per share.

The provider blood management systems for health care providers and blood collectors posted revenue of $241.6 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $233.5 million.

Haemonetics expects full-year earnings in the range of $2.25 to $2.35 per share.

Haemonetics shares have risen 82 percent since the beginning of the year. The stock has more than doubled in the last 12 months.

—————

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.